Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiu He

Showing results (201-210 of 224) with videos related to

Pageof 23
Sort By:
Pain|May 13, 2014
Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in miceZhe Li, Shao-Qiu He, Qian Xu, et al.
Pain|December 17, 2013
MrgC agonism at central terminals of primary sensory neurons inhibits neuropathic painShao-Qiu He, Zhe Li, Yu-Xia Chu, et al.
Frontiers in Neurology|September 12, 2022
Novel machine learning models to predict pneumonia events in supratentorial intracerebral hemorrhage populations: An analysis of the <i>Risa-MIS-ICH</i> studyYan Zheng, Yuan-Xiang Lin, Qiu He, et al.
Chinese Medical Journal|February 9, 2010
A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in ChinaXiu-Zhen Zhang, Bo Wang, Jun Yang, et al.
Chinese Medical Journal|February 21, 2013
Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in ChinaYing Li, Miao Xuan, Bo Wang, et al.
Zhonghua Nei Ke Za Zhi|October 29, 2010
[A randomized, multicenter, active-controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with that of elcatonin in postmenopausal women with osteoporosis in China]Xiu-zhen Zhang, Li-ge Song, Bo Wang, et al.
Journal of Medicinal Chemistry|February 4, 2022
Thieno[2,3-<i>d</i>]pyrimidine-Based Positive Allosteric Modulators of Human Mas-Related G Protein-Coupled Receptor X1 (MRGPRX1)Ilyas Berhane, Niyada Hin, Ajit G Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent painZhe Li, Pang-Yen Tseng, Vinod Tiwari, et al.
Stroke and Vascular Neurology|May 15, 2024
Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in ChinaChunwang Li, Lingyun Zhuo, Yaqing Kang, et al.
Chinese Journal of Integrative Medicine|April 3, 2024
Naoxueshu Oral Liquid Accelerates Post-Craniotomy Hematoma Absorption in Patients: An Open-Label, Multicenter, and Randomized Controlled TrialQiu He, Fu-Xin Lin, Jin-Ye Su, et al.
Pageof 23

Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
Pain|May 13, 2014
Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in miceZhe Li, Shao-Qiu He, Qian Xu, et al.
Pain|December 17, 2013
MrgC agonism at central terminals of primary sensory neurons inhibits neuropathic painShao-Qiu He, Zhe Li, Yu-Xia Chu, et al.
Frontiers in Neurology|September 12, 2022
Novel machine learning models to predict pneumonia events in supratentorial intracerebral hemorrhage populations: An analysis of the <i>Risa-MIS-ICH</i> studyYan Zheng, Yuan-Xiang Lin, Qiu He, et al.
Chinese Medical Journal|February 9, 2010
A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in ChinaXiu-Zhen Zhang, Bo Wang, Jun Yang, et al.
Chinese Medical Journal|February 21, 2013
Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in ChinaYing Li, Miao Xuan, Bo Wang, et al.
Zhonghua Nei Ke Za Zhi|October 29, 2010
[A randomized, multicenter, active-controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with that of elcatonin in postmenopausal women with osteoporosis in China]Xiu-zhen Zhang, Li-ge Song, Bo Wang, et al.
Journal of Medicinal Chemistry|February 4, 2022
Thieno[2,3-<i>d</i>]pyrimidine-Based Positive Allosteric Modulators of Human Mas-Related G Protein-Coupled Receptor X1 (MRGPRX1)Ilyas Berhane, Niyada Hin, Ajit G Thomas, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2017
Targeting human Mas-related G protein-coupled receptor X1 to inhibit persistent painZhe Li, Pang-Yen Tseng, Vinod Tiwari, et al.
Stroke and Vascular Neurology|May 15, 2024
Prevalence, genetic and clinical characteristics in first-degree relatives of patients with familial cerebral cavernous malformations in ChinaChunwang Li, Lingyun Zhuo, Yaqing Kang, et al.
Chinese Journal of Integrative Medicine|April 3, 2024
Naoxueshu Oral Liquid Accelerates Post-Craniotomy Hematoma Absorption in Patients: An Open-Label, Multicenter, and Randomized Controlled TrialQiu He, Fu-Xin Lin, Jin-Ye Su, et al.
Pageof 23